Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China flag China · Delayed Price · Currency is CNY
79.98
-1.58 (-1.94%)
Nov 17, 2026, 3:00 PM CST

SHA:688578 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
6,5905,1873,5582,018790.94530.08
Other Revenue
0.240.240.040.060.060.02
6,5905,1873,5582,018791530.09
Revenue Growth
38.51%45.80%76.29%155.14%49.22%94409.97%
Cost of Revenue
307.01164.58143.4977.8747.1129.95
Gross Profit
6,2835,0233,4141,940743.9500.14
Selling, General & Admin
2,6412,2431,5781,052524.11366.44
Research & Development
479.76413.37314.49313.06175.71200.61
Other Operating Expenses
23.8269.2246.8126.65.112.79
Operating Expenses
3,1452,7261,9401,392705.26569.95
Operating Income
3,1382,2971,475548.338.64-69.81
Interest Expense
-0.11-0.13-0.07-0.16-0.33-0.61
Interest & Investment Income
90.3468.1867.0460.1933.0630.06
Currency Exchange Gain (Loss)
-5.66-5.661.94.3517.17-3.38
Other Non Operating Income (Expenses)
12.92-0.920.170.99-1.06-0.43
EBT Excluding Unusual Items
3,2352,3591,544613.6887.47-44.16
Gain (Loss) on Sale of Investments
32.6140.2928.8922.6732.3648.13
Gain (Loss) on Sale of Assets
-2.39-2.53-0.01-0.02-1.68-0.57
Other Unusual Items
116.09148.6545.6619.897.8514.88
Pretax Income
3,3822,5451,619656.2212618.27
Income Tax Expense
475.13355.83188.6712.05-4.52-
Net Income
2,9072,1891,430644.17130.5218.27
Net Income to Common
2,9072,1891,430644.17130.5218.27
Net Income Growth
46.60%53.10%121.97%393.54%614.22%-
Shares Outstanding (Basic)
450450450450450457
Shares Outstanding (Diluted)
450450450450450457
Shares Change
0.15%0.18%-0.18%0.09%-1.49%23.59%
EPS (Basic)
6.464.863.181.430.290.04
EPS (Diluted)
6.464.863.181.430.290.04
EPS Growth
46.38%52.83%122.38%393.10%625.00%-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
2,9372,1371,296606.77-52.21-162.95
Free Cash Flow Per Share
6.534.742.881.35-0.12-0.36
Dividend Per Share
1.2001.0000.6500.400--
Dividend Growth
50.00%53.85%62.50%---
Gross Margin
95.34%96.83%95.97%96.14%94.05%94.35%
Operating Margin
47.62%44.28%41.45%27.17%4.88%-13.17%
Profit Margin
44.11%42.20%40.19%31.92%16.50%3.45%
Free Cash Flow Margin
44.58%41.19%36.42%30.06%-6.60%-30.74%
EBITDA
3,1792,3361,511585.2558.8-56
EBITDA Margin
48.25%45.04%42.48%29.00%7.43%-10.56%
D&A For EBITDA
41.539.2836.3236.9420.1613.81
EBIT
3,1382,2971,475548.338.64-69.81
EBIT Margin
47.62%44.28%41.45%27.17%4.88%-13.17%
Effective Tax Rate
14.05%13.98%11.66%1.84%--
Revenue as Reported
6,5905,1873,5582,018791530.09
Advertising Expenses
----201.3822.44